Award

Ultrasensitive quantitative digital ELISA for C. difficile toxins in stool

Description: The recent increase in global incidence and severity of disease caused by toxigenic Clostridium difficile presents a major clinical and diagnostic problem. Current methods for diagnosis of C. difficile infection have major limitations and improved diagnostics are urgently needed. We propose to develop a simple stool test that combines high analytical sensitivity with the clinical specificity of C. difficile toxin detection o allow us to optimally classify those with and without disease. Specifically, we propose to develop and clinically validate ultrasensitive and quantitative "digital ELISA" assays for C. difficile toxins A and B in stool specimens. This work will establish a solid technological foundation for future development of a low-cost, automated assay platform and for large prospective clinical studies to evaluate assay utility for predicting clinical outcome and monitoring therapeutic response.
Funding type: research
Funder scheme: R21
Start date: 2013-01-17
End date: 2014-12-31
Investigator: NIRA POLLOCK (lead)
Field: Medicine
Funded outputs count: 6
Funder award ID: R21AI103612
OpenAlex ID: G1929100743
2016 · I. Patel, M. Wungjiranirun, et al. · Journal of Antimicrobial Chemotherapy · 24
2015 · Kelsey Shields, Roger V. Araujo-Castillo, et al. · Anaerobe · 109
2015 · Nira R. Pollock, Linan Song, et al. · Journal of Clinical Microbiology · 10
2013 · Hans H. Locher, Peter Seiler, et al. · Antimicrobial Agents and Chemotherapy · 106